SEC Filing Details
Document Details
Form
Filing Date
Nov 14, 2022
Document Date
09/30/22
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Protalix BioTherapeutics
Issuer
PROTALIX BIOTHERAPEUTICS, INC.